December 04, 2025 07:00 ET | Source: Vaxil Bio Ltd. Not for distribution by US newswire or in United States…
Topline results from Phase 2 ZEPHYR trial of ML-007C-MA for schizophrenia expected in the second half of 2026Topline results from…
QWEEN To Launch By Mid-February A disruptive new approach to make luxury jewellery invitationalBANGALORE, India, Dec. 4, 2025 /PRNewswire/ -- QWEEN,…
SINGAPORE, Dec. 04, 2025 (GLOBE NEWSWIRE) -- DayOne Data Centers, a Singapore-headquartered data center developer and operator, today announced that…
Lorenzo Grandi, STMicroelectronics’ President and CFO to speak at Barclays investor conference Geneva, December 4, 2025 - STMicroelectronics N.V. (“ST”)…
AHMEDABAD, India, Dec. 4, 2025 /PRNewswire/ -- Dessert Holdings, North America's leading premium dessert company and a Bain Capital portfolio company,…
Powered by agentic AI, new features help regulatory teams improve accuracy and enable faster, more confident decisions across the product…
Global oncology society calls for abstract submissions for research that is shaping the future of cancer care in advance of…
Together, they set the New Global Standard for Test and Quality Engineering SolutionsMONTREAL, Dec. 3, 2025 /PRNewswire/ -- Averna, a…
MINNEAPOLIS, Dec. 03, 2025 (GLOBE NEWSWIRE) -- NMDPSM, a global nonprofit leader in cell therapy, hired Jessica Kowal as chief…